Both pharmacists and the pharmaceutical industry responded to draft approval The Act of Drug and Health Products This Tuesday to the government. In a statement, the General Council of Drug Colleges He expressed his concern over the new price system.
Drug schools argue that new law establishes New drug choice model It must be selected and distributed every six months (identical group) cheap medicine or medication of each type. In this way, they explain, “If a patient prescribes a drug that is not chosen, The pharmacist should change it The selected or the patient’s price should be paid to the difference. “
This situation would lead to the members of the situation, “to reduce the adoption of treatments and increase the risk Errors And complications associated with the use of drugs, by frequently replacing the distributed drug. ”
“Drugs that see our ability to change the drugs, but we don’t want to do this for just economic reason and health reasons. This new system keeps us in the determination to constantly change the drug And people with vulnerable and polymedicted people reflect the most serious problem, because of the confusion that the patient can create, “the general council chairman Jessas Aguiler explains.
Losses of employment and pharmacies
Pharmaceutical schools also use a new method by controlling selected drugs, Will greatly reduce the preferences and availability of the drug In the pharmacy, and creating delivery problems that make the treatment of treatment. “As a value, this may have negative effects Reduction in employment losses and number of pharmaciesThis will be directly affected by the rule, which will affect their quality.
Although the Council is favorable to the introduction of pharmacist’s professional development activities “, for example, the first prescribed drugs are given to the pharmacist to take part in the coordination of the basic health areas -only these benefits can be taken. The stability, access and reliability of the pharmacological network set The community, this draft is at risk with the law.
Asks for the quality of the pharmaceutical industry
For its part, Prilaindustria And abundance Associations They have promised in a statement to control the price of drugs from patent “Pharmaceuticals and industrial fabrics cause risk Drug in Spain. “In its report, groups ensure that this proposal will create a” automatic course “to reduce the prices of drugs from the patent, which is” to continue the production of many drugs in Spain, to intensify the current problems of the drug distribution, and in the market that is already very pressing in Spain and Europe. “
As far as these associations are concerned, this action does not apply to the strategy of the pharmaceutical industry, however, the Spanish drug is “subconscious” for industrial fabric. They point out that “we really need an alternative model that changes the selected price system controlled in the draft law.” Clear decisions must be made, and in any protocol text, Reflects the strategy of the field. “When the strategic autonomy of the country becomes a special fitness, we must strengthen the competitiveness of large and small companies that create our biological and pharmaceutical environmental system, and this should be a basic pillar for health and future. Therefore, they request that the preliminary draft of a law be changed to the sector, which considers vertempratora.
In addition to the Formindastria, the associations of this sector, such as Spanish General Medicins (this text has been subscribed (this text has been subscribed)Asg.Aelmhu), The Spanish Association of Best Chemical Products (Abaquim), Health Cellbare Association (ANEFP) And the Spanish Association of Biosimillar Drugs (Biosim).
(Tagstotranslate) nationality
Story Credit
